RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on relapsed leukemia in new trial
Disease control OngoingThis study tests a treatment called AUTO1, which uses a patient's own immune cells (T cells) that are modified in a lab to find and attack leukemia cells. It is for adults whose B cell acute lymphoblastic leukemia has come back or not responded to standard treatments. The goal is…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New CAR t therapy targets BAFFR to fight Hard-to-Treat leukemia
Disease control OngoingThis early-phase study tests a new type of immunotherapy called BAFFR-targeting CAR T cells for adults whose B-cell acute lymphoblastic leukemia has come back or not responded to at least two prior treatments. The therapy uses the patient's own immune cells, modified to recognize…
Matched conditions: RELAPSED OR REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE1 • Sponsor: PeproMene Bio, Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC